PetVivo Holdings, Inc. (PETV) stock: key figures, P/E, revenue and dividend

Health Care · United States · ISIN US7168174081

Price
0.52 USD
Market cap
19.54 m USD
P/E (2026)
–
P/S (2026)
17.12
Dividend yield
0.00 %
Net margin
-917.45 %
Return on equity (ROE)
-476.20 %
Return on assets (ROA)
-292.83 %

PetVivo Holdings, Inc. financials

Fiscal year20252026
Revenue1.13 m USD1.14 m USD
Gross profit994,856.00 USD754,751.00 USD
Operating income-8.06 m USD-9.06 m USD
EBIT-8.40 m USD-10.47 m USD
Net income-8.40 m USD-10.47 m USD
Diluted EPS – continuing operations-0.41 USD-0.38 USD

Full history since 2009, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About PetVivo Holdings, Inc.

PetVivo Holdings, Inc., a biomedical device company, manufactures, commercializes, and licenses medical devices and therapeutics for animals in the United States. The company's lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. It also provides therapeutic devices for veterinary and human clinical applications. The company is based in Edina, Minnesota.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.